Sign Out
Caution should be exercised when administering the product to the following: Patients with severe heart failure.
Patients with severe renal impairment (creatinine clearance <35 mL/min).
Elderly patients who have a generally altered sensitivity to different types of drugs.
Effects on Ability to Drive and Use Machine: This product may occasionally cause drowsiness. Therefore, caution should be recommended when driving a car or operating machinery.
Use in Children: 1) Levodropropizine (LEVOTICS CR) is a controlled-release tablet, so a different formulation, which can be split, should be used.
2) Efficacy studies after administration to children less than 2 years of age have not been performed to a sufficient extent and therefore the product should be administered with caution to this patient group.
